| Patricia Coyle, OT | |
|
314 S Manning Blvd, Albany, NY 12208-1708 | |
| (518) 453-2273 | |
| Not Available |
| Full Name | Patricia Coyle |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 314 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396757043 | NPI | - | NPPES |
| 00012981 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 012981 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Coyle, OT 314 S Manning Blvd, Albany, NY 12208-1708 Ph: () - | Patricia Coyle, OT 314 S Manning Blvd, Albany, NY 12208-1708 Ph: (518) 453-2273 |
News Archive
Celadrin is a novel compound developed through a proprietary process. The product is an all-natural ingredient which has been clinically shown to provide joint health, flexibility and improved quality of life on a cumulative basis with no reported side effects.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
A large worldwide study has found that, contrary to popular thought, low-salt diets may not be beneficial and may actually increase the risk of cardiovascular disease (CVD) and death compared to average salt consumption.
In neurodegenerative conditions like Parkinson's disease, a specific group of neurons start to die one by one, causing movement problems and other symptoms. Scientists have long focused on finding out why these neurons die. Now it turns out, they might not even be dead.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
› Verified 8 days ago
Amy Sommerville, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1367 Washington Ave, Suite 100, Albany, NY 12206 Phone: 518-438-7926 Fax: 518-438-8364 | |
Micah Ross Cutler, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-437-5861 | |
Leah Campbell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Northern Blvd, Albany, NY 12204 Phone: 518-471-3195 | |
Madison Rose Langey, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 700 S Pearl St, Albany, NY 12202 Phone: 518-427-2214 | |
Linnea Mesick, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-437-5717 Fax: 518-437-5579 | |
Amy Kiyanitsa, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Albany, NY 12208 Phone: 518-262-3290 | |
Caitlin Mary Whelan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Rapp Rd, Albany, NY 12203 Phone: 518-867-3061 |